Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lagis Enterprise CoROCO:6730 91 FCF Margin % is 34.50% as of Dec. 2025, which is 175% above its 10-year median of 12.56. GuruFocus rates ROCO:6730 with a GF Score™ of 91/100 and a GF Value™ of NT$43.10 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Lagis Enterprise Co ranks better than 69.65% on this metric.
The historical rank and industry rank for Lagis Enterprise Co's FCF Margin % or its related term are showing as below:
ROCO:6730'
s FCF Margin % Range Over the Past 10 Years
Min: -44.47 Med: 12.56 Max: 24.29
Current: 8.13
During the past 10 years, the highest FCF Margin % of Lagis Enterprise Co was 24.29%. The lowest was -44.47%. And the median was 12.56%.
ROCO:6730's FCF Margin % is ranked better than 69.65% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: -0.54
vs ROCO:6730: 8.13
Lagis Enterprise Co FCF Margin % Related Terms
Lagis Enterprise Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Lagis Enterprise Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6730 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Lagis Enterprise Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lagis Enterprise Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lagis Enterprise Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Lagis Enterprise Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lagis Enterprise Co (ROCO:6730) has a FCF Margin % of 34.50% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lagis Enterprise Co and its competitors. This is 175% above median its historical median of 12.56. According to the industry distribution chart, Lagis Enterprise Co ranks #248 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 30.4%.
Is Lagis Enterprise Co's FCF Margin % too high?
Lagis Enterprise Co's current FCF Margin % of 34.50% is 175% above median its 10-year median of 12.56. Based on the distribution chart, Lagis Enterprise Co ranks #248 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lagis Enterprise Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lagis Enterprise Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lagis Enterprise Co ranks #248 out of 817 companies for FCF Margin %. This puts Lagis Enterprise Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lagis Enterprise Co and its competitors. Lagis Enterprise Co's current FCF Margin % is 34.50%, which is 175% above median its own 10-year median of 12.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lagis Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Lagis Enterprise Co (ROCO:6730) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$43.10, compared to a current price of NT$37.50 — trading 13% below its estimated fair value. The current FCF Margin % is 34.50%, which is 175% above median its 10-year median of 12.56. Lagis Enterprise Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Lagis Enterprise Co (ROCO:6730), the current FCF Margin % is 34.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lagis Enterprise Co (ROCO:6730) Overvalued in 2026?
Based on GuruFocus' analysis, Lagis Enterprise Co stock appears to be undervalued.
The current stock price of NT$37.50 is trading 13% below its estimated GF Value™ of NT$43.10.
GuruFocus considers Lagis Enterprise Co to be Modestly Undervalued.
Key valuation signals for ROCO:6730:
FCF Margin %: 34.50% (175% above median its 10-year median of 12.56)
GF Value™: NT$43.10 vs. price of NT$37.50 (13% below fair value)
No single metric tells the full story. See the ROCO:6730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lagis Enterprise Co Ltd is a medical device development company that designs, patents, and markets medical devices for the laparoscopic and endoscopic surgical markets. Its product portfolio includes Access, Endo Devices, Specimen Retrieval products, Suction Irrigation systems, Training systems, and accessories.
91GF Score
Get the complete analysis for ROCO:6730
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6730 has been successfully added to your 
